Ireland
--:--IST
Starting soon Not applicable

Regenerative Potentials of Mature Mandibular Molars With Symptomatic Irreversible Pulpitis Enhanced With Different Scaffolds

NCT07196683 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-07-01
Last updated
2026-03-27

Condition(s) studied

Symptomatic Irreversible Pulpitis (SIP)

Investigational drug(s) / intervention(s)

Regenerative pulpotomy

Regenerative pulpotomy: Regenerative pulpotomy combines the use of hydraulic calcium silicate based cements; MTA, together with biodegradable scaffolds such as PRF.

Study summary

The current study aims to assess the influence of different scaffolds on postoperative pain and success rate of pulpotomy in mandibular mature molars with symptomatic irreversible pulpitis

Eligibility

Sex
ALL
Min age
15 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: * ASA I patients who are free from any physical or mental handicapping condition with no underlying systemic disease. * Age between 15-40 years. * Males \& Females. * Patients' acceptance to participate in the trial. * Patients who can understand pain scale and can sign the informed consent (Appendix I). * Mature mandibular fist molars: * Diagnosed clinically with symptomatic irreversible pulpitis and normal periapical tissue. * Giving a positive response to pulp sensitivity testing. * Having negative response to percussion. * Having normal radiographic appearance of periapical tissues. * Having bright red color of pulp tissue, with hemorrhage control within 10 mins, upon access cavity preparation. Exclusion Criteria: * Pregnant and lactating females. * Patients with physical or mental handicapping conditions. * Patients unwilling to participate in a 12-months follow up. * Mandibular first molars with: * Immature roots. * Negative response to pulp sensitivity testing. * Positive response to percussion. * Radiographic evidence of periapical lesions, external or internal root resorption, vertical root fracture, or calcification. * Intraoral swelling or fistula. * Lack of pulpal bleeding, or inability to achieve hemostasis of the bleeding pulp within 10 mins, upon access cavity preparation.

Primary outcome measure(s)

  • Intensity of postoperative pain — 6, 12, 24, and 72 hours postoperatively
    measured using numerical rating scale

Trial sites (1)

FacilityCityRegionStatus
Faculty of Dentistry, Cairo University Cairo Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07196683 on ClinicalTrials.gov ↗ ← All trials in Egypt